 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Baraclude.
Condition  |
Reviews | Compare | Avg. Ratings |
|
|---|---|---|---|---|
| Hepatitis B | 0 reviews | 9 medications | 10 |
|
There are no reviews - Be the first
Popular cholesterol-lowering statins may also lower risk for liver cancer among people with hepatitis B, a new study shows. Hepatitis B, an inflammation of the...
More than half (51.4 percent) of American adults at risk for hepatitis B infection have not been vaccinated, a new study says. People at risk for hepatitis B...
Jan 19, 2012 - Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Viread (tenofovir disoproxil fumarate) in...
• 96-week study in a population of nucleos(t)ide-naïve patients with chronic hepatitis B (CHB) infection • Data presented at the American Association...
Customers in nail salons and barbershops may be at risk for hepatitis infection if the tools used are improperly cleaned, a new U.S. study suggests. While...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
